Link to this page
Medical Subject Headings
| Preferred Name | Imipramine | |
| Synonyms |
Janimine Imizin 4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2) Imipramine Pamoate Norchlorimipramine Imipramine Hydrochloride Imidobenzyle Melipramine Tofranil 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- Pryleugan Imipramine Monohydrochloride |
|
| Definitions |
The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D007099 |
|
| altLabel |
Janimine Imizin 4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2) Imipramine Pamoate Norchlorimipramine Imipramine Hydrochloride Imidobenzyle Melipramine Tofranil 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- Pryleugan Imipramine Monohydrochloride
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C0022339 C0701353 C0701354 C0025231 C0304368 C0589978 C4082435 C0020934
|
|
| DC |
1
|
|
| definition |
The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
|
|
| DX |
19660101
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
BKE5Q1J60U MC34P30298 OGG85SX4E4 0
|
|
| isa | ||
| LT |
TRD
|
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C033803 http://purl.bioontology.org/ontology/MESH/C040311 http://purl.bioontology.org/ontology/MESH/C002921 http://purl.bioontology.org/ontology/MESH/C030721 http://purl.bioontology.org/ontology/MESH/C061446 http://purl.bioontology.org/ontology/MESH/C107213 http://purl.bioontology.org/ontology/MESH/C012269 http://purl.bioontology.org/ontology/MESH/C024316 http://purl.bioontology.org/ontology/MESH/C036691 http://purl.bioontology.org/ontology/MESH/C027682 http://purl.bioontology.org/ontology/MESH/C065353 http://purl.bioontology.org/ontology/MESH/C514870 |
|
| MDA |
19990101
|
|
| MMR |
20180702
|
|
| MN |
D03.633.300.240.485
|
|
| notation |
D007099
|
|
| PA |
D018759 D000929
|
|
| prefLabel |
Imipramine
|
|
| RR |
113-52-0 (mono-HCl) BKE5Q1J60U MC34P30298 50-49-7 (Imipramine)
|
|
| TERMUI |
T021239 T021234 T360354 T000943560 T021232 T021233 T000943562 T021238 T021237 T021231 T021235 T021236
|
|
| TH |
NLM (1999) FDA SRS (2018) FDA SRS (2014) NLM (2019) UNK (19XX) INN (19XX) USP (19XX) BAN (19XX)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |